Sangdeuk Lee, Chief Executive Officer of Bioinfra co., Ltd., signed an agreement to acquire 52.7% stake in Bioinfra co., Ltd. from AIBIT Co., Ltd. (KOSDAQ:A039230) for KRW 3.5 billion on July 31, 2018. Under the terms of the acquisition, 0.73 million shares of Bioinfra will be acquired. The Board of Directors of AIBIT passed a resolution on September 18, 2018 and the deal is expected to complete on September 20, 2018. Sangdeuk Lee, Chief Executive Officer of Bioinfra co., Ltd., cancelled the acquisition of 52.7% stake in Bioinfra co., Ltd. from AIBIT Co., Ltd. (KOSDAQ:A039230) on July 31, 2019.